Literature DB >> 10350450

Assessing the costs of healthcare technologies in clinical trials.

K Johnston1, M J Buxton, D R Jones, R Fitzpatrick.   

Abstract

Mesh:

Year:  1999        PMID: 10350450

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  30 in total

1.  Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: cost effectiveness.

Authors:  P Bower; S Byford; B Sibbald; E Ward; M King; M Lloyd; M Gabbay
Journal:  BMJ       Date:  2000-12-02

2.  Unexpected yes- and no-answering behaviour in the discrete choice approach to elicit willingness to pay: a methodological comparison with payment cards.

Authors:  Thomas Hammerschmidt; Hans-Peter Zeitler; Reiner Leidl
Journal:  Int J Health Care Finance Econ       Date:  2003-09

3.  Costs of inflammatory bowel disease in Germany.

Authors:  Renee Stark; Hans-Helmut König; Reiner Leidl
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Estimating 'costs' for cost-effectiveness analysis.

Authors:  Alec Miners
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 5.  Emergent Challenges in Determining Costs for Economic Evaluations.

Authors:  Josephine C Jacobs; Paul G Barnett
Journal:  Pharmacoeconomics       Date:  2017-02       Impact factor: 4.981

Review 6.  Identification of Key Cost Generating Events for Idiopathic Pulmonary Fibrosis: A Systematic Review.

Authors:  Shalvaree Vaidya; Clare L Hibbert; Elizabeth Kinter; Stefan Boes
Journal:  Lung       Date:  2016-11-19       Impact factor: 2.584

7.  Economic evaluation of diagnosing and excluding ectopic pregnancy.

Authors:  C J Wedderburn; P Warner; B Graham; W C Duncan; H O D Critchley; A W Horne
Journal:  Hum Reprod       Date:  2009-11-20       Impact factor: 6.918

8.  Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis.

Authors:  R Suri; R Grieve; C Normand; C Metcalfe; S Thompson; C Wallis; A Bush
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

9.  Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses.

Authors:  Peter Bower; Sarah Byford; Julie Barber; Jennifer Beecham; Sharon Simpson; Karin Friedli; Roslyn Corney; Michael King; Ian Harvey
Journal:  BMJ       Date:  2003-06-07

10.  Cost-effectiveness analysis of cognitive behaviour therapy for treatment of minor or mild-major depression in elderly patients with type 2 diabetes: study protocol for the economic evaluation alongside the MIND-DIA randomized controlled trial (MIND-DIA CEA).

Authors:  Nadja Chernyak; Frank Petrak; Kristin Plack; Martin Hautzinger; Matthias J Müller; Guido Giani; Andrea Icks
Journal:  BMC Geriatr       Date:  2009-07-01       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.